NANOPARTICLES FOR USE IN BIOADHESION

(19)

(11)

EP 3 044 163 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	05.01.2022 Bulletin 2022/01

(45)	Mention of the grant of the patent:
	07.07.2021 Bulletin 2021/27

(21)	Application number: 14766435.3

(22)	Date of filing: 09.09.2014

(51)

International Patent Classification (IPC):

B82Y 30/00^(2011.01)
A61K 8/25^(2006.01)
A61L 24/00^(2006.01)
A61L 27/10^(2006.01)
A61L 27/50^(2006.01)

A61Q 3/02^(2006.01)
A61K 9/14^(2006.01)
A61L 24/02^(2006.01)
A61L 27/12^(2006.01)
A61L 27/52^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	A61L 24/0031; A61L 24/001; A61L 27/50; A61K 9/14; A61L 27/52; A61L 27/10; A61L 27/105; G02C 7/04; A61L 27/12; A61L 2400/12; A61K 2800/413; A61L 24/02; A61F 2/02; A61F 2220/005; B82Y 30/00; A61Q 3/02; A61K 8/25

(86)	International application number:
	PCT/EP2014/069233

(87)	International publication number:
	WO 2015/036410 (19.03.2015 Gazette 2015/11)

(54)	NANOPARTICLES FOR USE IN BIOADHESION NANOPARTIKEL ZUR VERWENDUNG IN BIOADHÄSION NANOPARTICULES POUR UTILISATION EN BIOADHÉRENCE

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

10.09.2013 EP 13306243

(43)	Date of publication of application:
	20.07.2016 Bulletin 2016/29

(73)	Proprietor: Ecole Supérieure de Physique et de Chimie Industrielles de la Ville de Paris
	75005 Paris (FR)

(72)	Inventors:
	MARCELLAN, Alba F-94600 Choisy-le-Roi (FR) LEIBLER, Ludwik F-75006 Paris (FR)

(74)	Representative: Corizzi, Valérie
	PACT-IP 37, rue Royale 92210 Saint-Cloud 92210 Saint-Cloud (FR)

(56)

References cited: :

WO-A2-02/41765
US-A1- 2013 052 712

US-A1- 2009 275 526

MAHESHWARI M ET AL: "DEVELOPMENT OF TETRACYCLINE-SERRATIOPEPTIDASE-CONTAINING PERIODONTAL GEL: FORMULATION AND PRELIMINARY CLINICAL STUDY", AAPS PHARMSCITECH, SPRINGER NEW YORK LLC, US, vol. 7, no. 3, 1 January 2006 (2006-01-01) , pages E1-E10, XP002547740, ISSN: 1530-9932, DOI: 10.1208/PT070376 [retrieved on 2006-09-15]
AGUZZI ET AL: "Use of clays as drug delivery systems: Possibilities and limitations", APPLIED CLAY SCIENCE, ELSEVIER SCIENCE, NL, vol. 36, no. 1-3, 16 March 2007 (2007-03-16), pages 22-36, XP005932574, ISSN: 0169-1317, DOI: 10.1016/J.CLAY.2006.06.015

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).